市場調査レポート

商品コード

1344333

神経インターベンション装置市場：製品別、適応症別、用途別：世界の機会分析と産業予測、2023-2032年

Neurointerventional Devices Market By Product, By Indication, By Application : Global Opportunity Analysis and Industry Forecast, 2023-2032

出版日: 2023年06月01日 | 発行: Allied Market Research

| ページ情報: 英文 282 Pages | 納期: 2～3営業日

価格

PDF (Single User License)

USD 5,730 898,234円

レポートPDFを1つのPCでご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回だけ可能です。印刷したレポートの利用もPDFのライセンス保持者になります。回覧のための複製も原則NGです。

PDF (5-user License)

USD 6,450 1,011,102円

レポートPDFを5名でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回可能です。印刷したレポートの利用もPDFのライセンス保持者5名となります。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 9,600 1,504,896円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

神経インターベンション装置市場は2022年に26億米ドルと評価され、2023年から2032年にかけてCAGR 7.5%で成長し、2032年には53億米ドルに達すると推定されています。

神経インターベンション装置は、神経インターベンション放射線治療分野で使用される医療機器の専門カテゴリーです。これらの機器は、特に脳や脊髄の血管に影響を及ぼす様々な神経疾患の診断や治療を目的として設計されています。神経インターベンショナル手技では、カテーテル、ワイヤー、ステント、その他の器具を用いた低侵襲手技により、患部へのアクセスや治療が行われます。神経インターベンション装置は、虚血性脳卒中、出血性脳卒中、脳動脈瘤、AVM、中枢神経系のその他の血管異常などの疾患の管理において重要な役割を果たしています。これらの機器は、従来の開腹手術と比較してリスクを低減し、回復時間を短縮した低侵襲治療を可能にすることで、神経インターベンショナル・ラジオロジー分野に革命をもたらしました。

神経インターベンション装置は、神経血管疾患の診断と治療において重要な役割を果たしています。例えば、脳血管撮影では、血管を可視化し、異常を検出するためにカテーテルや画像システムが使用されます。塞栓コイルやフローダイバータは、血液凝固の促進や血流の方向転換によって動脈瘤の治療に役立っています。このように、神経疾患の罹患率の増加は、神経インターベンション手技や機器の需要を急増させ、市場の成長を促進します。さらに、低侵襲処置への嗜好の高まりが神経インターベンション装置市場の成長を形成しています。低侵襲手術は、従来の開腹手術に比べて、侵襲性の低減、入院期間の短縮、回復の早さ、精度と結果の向上、合併症のリスクの低減など、いくつかの利点を提供することで、神経インターベンションの分野に革命をもたらしました。低リスクで回復が早いという利点から、低侵襲手術に対する患者の嗜好が急増しています。

国立医学図書館が2020年に行った調査では、低侵襲治療に対する患者の嗜好は過去16年間で36％上昇したと報告されています。低侵襲治療では、小さな切開創から患部にアクセスし、多くの場合、透視や血管造影などの画像診断技術によって誘導されます。神経インターベンション装置は、医師が複雑な血管をナビゲートし、正確に治療を行うことを可能にします。脳梗塞と診断された患者の血栓除去術では、カテーテル、ガイドワイヤー、バルーンが使用され、脳内の血栓を除去するのに役立っています。

市場の定義と範囲
主な調査結果
- 影響要因
- 主な投資機会
ポーターのファイブフォース分析
- 供給企業の交渉力の低さ
- 新規参入業者の脅威が低い
- 代替品の脅威が低い
- 競合の激しさが低い
- 買い手の交渉力が低い
市場力学
- 促進要因
  - 神経疾患の有病率の急増
  - 神経疾患に対する意識の高まり
  - 最小侵襲手技に対する需要の高まり
- 抑制要因
  - 神経インターベンション装置の高価格
- 機会
  - 神経インターベンション装置の技術的進歩
COVID-19市場への影響分析

第4章神経インターベンション装置市場：製品別

概要
ステント
塞栓用コイル
カテーテル
ワイヤー
その他

第5章神経インターベンション装置市場：適応疾患別

概要
脳動脈瘤
脳卒中
その他

第6章神経インターベンション装置市場：用途別

概要
病院
外来手術センター
その他

第7章神経インターベンション装置市場：地域別

概要
北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- その他欧州
アジア太平洋
- 日本
- 中国
- オーストラリア
- インド
- 韓国
- その他アジア太平洋地域
ラテンアメリカ・中東・アフリカ
- ブラジル
- サウジアラビア
- 南アフリカ
- その他の地域

第8章競争情勢

イントロダクション
主要成功戦略
主要10企業の製品マッピング
競合ダッシュボード
競合ヒートマップ
主要企業のポジショニング、2022年

第9章企業プロファイル

Stryker Corporation.
Johnson & Johnson
Medtronic plc
Terumo Corporation
Integer Holdings Corporation
Lepu Medical Technology（Beijing）Co., Ltd
Balt Group
Merit Medical Systems Inc.
Cook Group Inc
Penumbra, Inc

図表

LIST OF TABLES

TABLE 01. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 02. NEUROINTERVENTIONAL DEVICES MARKET FOR STENTS, BY REGION, 2022-2032 ($MILLION)
TABLE 03. NEUROINTERVENTIONAL DEVICES MARKET FOR EMBOLIC COILS, BY REGION, 2022-2032 ($MILLION)
TABLE 04. NEUROINTERVENTIONAL DEVICES MARKET FOR CATHETER, BY REGION, 2022-2032 ($MILLION)
TABLE 05. NEUROINTERVENTIONAL DEVICES MARKET FOR WIRES, BY REGION, 2022-2032 ($MILLION)
TABLE 06. NEUROINTERVENTIONAL DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 07. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 08. NEUROINTERVENTIONAL DEVICES MARKET FOR BRAIN ANEURYSM, BY REGION, 2022-2032 ($MILLION)
TABLE 09. NEUROINTERVENTIONAL DEVICES MARKET FOR STROKE, BY REGION, 2022-2032 ($MILLION)
TABLE 10. NEUROINTERVENTIONAL DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 11. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 12. NEUROINTERVENTIONAL DEVICES MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
TABLE 13. NEUROINTERVENTIONAL DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2032 ($MILLION)
TABLE 14. NEUROINTERVENTIONAL DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 15. NEUROINTERVENTIONAL DEVICES MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 18. NORTH AMERICA NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 19. NORTH AMERICA NEUROINTERVENTIONAL DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 20. U.S. NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 21. U.S. NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 22. U.S. NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 23. CANADA NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 24. CANADA NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 25. CANADA NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 26. MEXICO NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 27. MEXICO NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 28. MEXICO NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 29. EUROPE NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 30. EUROPE NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 31. EUROPE NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 32. EUROPE NEUROINTERVENTIONAL DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 33. GERMANY NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 34. GERMANY NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 35. GERMANY NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 36. FRANCE NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 37. FRANCE NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 38. FRANCE NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 39. UK NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 40. UK NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 41. UK NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 42. ITALY NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 43. ITALY NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 44. ITALY NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 45. SPAIN NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 46. SPAIN NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 47. SPAIN NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 48. REST OF EUROPE NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 49. REST OF EUROPE NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 50. REST OF EUROPE NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 52. ASIA-PACIFIC NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 53. ASIA-PACIFIC NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 54. ASIA-PACIFIC NEUROINTERVENTIONAL DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 55. JAPAN NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 56. JAPAN NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 57. JAPAN NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 58. CHINA NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 59. CHINA NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 60. CHINA NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 61. AUSTRALIA NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 62. AUSTRALIA NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 63. AUSTRALIA NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 64. INDIA NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 65. INDIA NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 66. INDIA NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 67. SOUTH KOREA NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 68. SOUTH KOREA NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 69. SOUTH KOREA NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 73. LAMEA NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 74. LAMEA NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 75. LAMEA NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 76. LAMEA NEUROINTERVENTIONAL DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 77. BRAZIL NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 78. BRAZIL NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 79. BRAZIL NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 80. SAUDI ARABIA NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 81. SAUDI ARABIA NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 82. SAUDI ARABIA NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 83. SOUTH AFRICA NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 84. SOUTH AFRICA NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 85. SOUTH AFRICA NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 86. REST OF LAMEA NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 87. REST OF LAMEA NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 88. REST OF LAMEA NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 89. STRYKER CORPORATION.: KEY EXECUTIVES
TABLE 90. STRYKER CORPORATION.: COMPANY SNAPSHOT
TABLE 91. STRYKER CORPORATION.: PRODUCT SEGMENTS
TABLE 92. STRYKER CORPORATION.: PRODUCT PORTFOLIO
TABLE 93. STRYKER CORPORATION.: KEY STRATERGIES
TABLE 94. JOHNSON & JOHNSON: KEY EXECUTIVES
TABLE 95. JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 96. JOHNSON & JOHNSON: PRODUCT SEGMENTS
TABLE 97. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 98. JOHNSON & JOHNSON: KEY STRATERGIES
TABLE 99. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 100. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 101. MEDTRONIC PLC: PRODUCT SEGMENTS
TABLE 102. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 103. TERUMO CORPORATION: KEY EXECUTIVES
TABLE 104. TERUMO CORPORATION: COMPANY SNAPSHOT
TABLE 105. TERUMO CORPORATION: PRODUCT SEGMENTS
TABLE 106. TERUMO CORPORATION: PRODUCT PORTFOLIO
TABLE 107. TERUMO CORPORATION: KEY STRATERGIES
TABLE 108. INTEGER HOLDINGS CORPORATION: KEY EXECUTIVES
TABLE 109. INTEGER HOLDINGS CORPORATION: COMPANY SNAPSHOT
TABLE 110. INTEGER HOLDINGS CORPORATION: PRODUCT SEGMENTS
TABLE 111. INTEGER HOLDINGS CORPORATION: PRODUCT PORTFOLIO
TABLE 112. INTEGER HOLDINGS CORPORATION: KEY STRATERGIES
TABLE 113. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD: KEY EXECUTIVES
TABLE 114. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD: COMPANY SNAPSHOT
TABLE 115. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD: PRODUCT SEGMENTS
TABLE 116. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD: SERVICE SEGMENTS
TABLE 117. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD: PRODUCT PORTFOLIO
TABLE 118. BALT GROUP: KEY EXECUTIVES
TABLE 119. BALT GROUP: COMPANY SNAPSHOT
TABLE 120. BALT GROUP: PRODUCT SEGMENTS
TABLE 121. BALT GROUP: PRODUCT PORTFOLIO
TABLE 122. MERIT MEDICAL SYSTEMS INC.: KEY EXECUTIVES
TABLE 123. MERIT MEDICAL SYSTEMS INC.: COMPANY SNAPSHOT
TABLE 124. MERIT MEDICAL SYSTEMS INC.: PRODUCT SEGMENTS
TABLE 125. MERIT MEDICAL SYSTEMS INC.: PRODUCT PORTFOLIO
TABLE 126. COOK GROUP INC: KEY EXECUTIVES
TABLE 127. COOK GROUP INC: COMPANY SNAPSHOT
TABLE 128. COOK GROUP INC: PRODUCT SEGMENTS
TABLE 129. COOK GROUP INC: SERVICE SEGMENTS
TABLE 130. COOK GROUP INC: PRODUCT PORTFOLIO
TABLE 131. PENUMBRA, INC: KEY EXECUTIVES
TABLE 132. PENUMBRA, INC: COMPANY SNAPSHOT
TABLE 133. PENUMBRA, INC: PRODUCT SEGMENTS
TABLE 134. PENUMBRA, INC: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN NEUROINTERVENTIONAL DEVICES MARKET (2023-2032)
FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 05. LOW THREAT OF NEW ENTRANTS
FIGURE 06. LOW THREAT OF SUBSTITUTES
FIGURE 07. LOW INTENSITY OF RIVALRY
FIGURE 08. LOW BARGAINING POWER OF BUYERS
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALNEUROINTERVENTIONAL DEVICES MARKET
FIGURE 09. NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022(%)
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF NEUROINTERVENTIONAL DEVICES MARKET FOR STENTS, BY COUNTRY 2022 AND 2032(%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF NEUROINTERVENTIONAL DEVICES MARKET FOR EMBOLIC COILS, BY COUNTRY 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF NEUROINTERVENTIONAL DEVICES MARKET FOR CATHETER, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF NEUROINTERVENTIONAL DEVICES MARKET FOR WIRES, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF NEUROINTERVENTIONAL DEVICES MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 15. NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF NEUROINTERVENTIONAL DEVICES MARKET FOR BRAIN ANEURYSM, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF NEUROINTERVENTIONAL DEVICES MARKET FOR STROKE, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF NEUROINTERVENTIONAL DEVICES MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF NEUROINTERVENTIONAL DEVICES MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF NEUROINTERVENTIONAL DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF NEUROINTERVENTIONAL DEVICES MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 23. NEUROINTERVENTIONAL DEVICES MARKET BY REGION, 2022
FIGURE 24. U.S. NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 25. CANADA NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 26. MEXICO NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 27. GERMANY NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 28. FRANCE NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 29. UK NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 30. ITALY NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 31. SPAIN NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 32. REST OF EUROPE NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 33. JAPAN NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 34. CHINA NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 35. AUSTRALIA NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 36. INDIA NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 37. SOUTH KOREA NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 38. REST OF ASIA-PACIFIC NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 39. BRAZIL NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 40. SAUDI ARABIA NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 41. SOUTH AFRICA NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 42. REST OF LAMEA NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 43. TOP WINNING STRATEGIES, BY YEAR
FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 47. COMPETITIVE DASHBOARD
FIGURE 48. COMPETITIVE HEATMAP: NEUROINTERVENTIONAL DEVICES MARKET
FIGURE 49. TOP PLAYER POSITIONING, 2022
FIGURE 50. STRYKER CORPORATION.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 51. STRYKER CORPORATION.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 52. STRYKER CORPORATION.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 53. JOHNSON & JOHNSON: NET SALES, 2020-2022 ($MILLION)
FIGURE 54. JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 55. JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 56. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
FIGURE 57. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 58. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 59. TERUMO CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 60. TERUMO CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 61. TERUMO CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 62. INTEGER HOLDINGS CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 63. INTEGER HOLDINGS CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 64. INTEGER HOLDINGS CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 65. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 66. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 67. MERIT MEDICAL SYSTEMS INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 68. MERIT MEDICAL SYSTEMS INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 69. MERIT MEDICAL SYSTEMS INC.: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 70. PENUMBRA, INC: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 71. PENUMBRA, INC: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 72. PENUMBRA, INC: REVENUE SHARE BY SEGMENT, 2022 (%)

Product Code: A14456

According to a new report published by Allied Market Research, titled, "Neurointerventional Devices Market," The neurointerventional devices market was valued at $2.6 billion in 2022, and is estimated to reach $5.3 billion by 2032, growing at a CAGR of 7.5% from 2023 to 2032. Neurointerventional devices are a specialized category of medical devices used in the field of neurointerventional radiology. These devices are designed to diagnose and treat various neurological conditions, particularly those affecting the blood vessels of the brain and spinal cord. Neurointerventional procedures involve minimally invasive techniques that utilize catheters, wires, stents, and other devices to access and treat the affected area. Neurointerventional devices play a crucial role in the management of conditions such as ischemic stroke, hemorrhagic stroke, brain aneurysms, AVMs, and other vascular abnormalities of the central nervous system. These devices have revolutionized the field of neurointerventional radiology by enabling minimally invasive treatments with reduced risks and faster recovery times compared to traditional open surgeries

Neurointerventional devices play a crucial role in the diagnosis and treatment of neurovascular conditions. For example, catheters and imaging systems are used during cerebral angiography to visualize blood vessels and detect abnormalities. Embolic coils and flow diverters help to treat aneurysms by promoting clotting or redirecting blood flow. Thus, rise in incidence of neurological disorders surge the demand for neurointerventional procedures and devices and propel the growth of the market. Furthermore, increase in preference towards minimally invasive procedures is shaping the growth of the neurointerventional devices market. Minimally invasive procedures have revolutionized the field of neurointerventional by offering several advantages over traditional open surgeries such as reduced invasiveness, shorter hospital stays, faster recovery, improved precision and outcomes, and lower risk of complications. Due to the advantage such as lower risk and faster recovery, there has been a spike in patient preference towards the minimally invasive procedures.

A study performed by the National Library of Medicine, in 2020, reported that the preference of patients toward minimally invasive treatments raised by 36% over the last 16 years. Minimally invasive procedures involve accessing the affected area through small incisions, often guided by imaging techniques such as fluoroscopy or angiography. Neurointerventional devices enable physicians to navigate complex blood vessels and deliver treatments precisely. Catheters, guidewires, and balloons are used in thrombectomy procedure in patient diagnosed with stroke, which helps to remove the blood clots in brain.

In addition, stents and flow diverters are also used to help restore blood flow in blocked or weakened vessels. Thus, the minimally invasive procedures have emerged as more efficient in terms of faster recovery of patient, lower risk management, and improved precision and outcomes, as compared to the traditional surgical methods, leading to high adoption of minimally invasive procedures by patients and healthcare professionals, resulting in the growth of the neurointerventional devices market.

In addition, rise in awareness of neurological disorders has emerged as a significant driver for the neurointerventional devices market. Neurological disorders encompass a range of conditions affecting the brain, spinal cord, and peripheral nervous system. Over recent years, rise in incidence of neurological disorders, advancements in diagnostic techniques, media coverage and advocacy efforts to spread awareness about the neurological disorders, and government initiatives towards treatment support of neurological disorders have led to increase in public awareness of these disorders.

For instance, The National Policy for Rare Diseases scheme, by government of India, has provision for financial support of up to Rs. 50 lakhs to the patients suffering from any category of the rare diseases and for treatment in the Centre of Excellence (CoE) mentioned in NPRD-2021. Moreover, rise in sedentary lifestyles, unhealthy diets, environmental factors, and aging population, further lead to various neurological disorder and boost the growth of the market. Conditions such as stroke, cerebral aneurysms, and arteriovenous malformations can have severe consequences if not diagnosed and treated promptly. Thus, the need for neurointerventional procedure increase the demand for neurointerventional device and propel the growth of the market. However, the high cost of neurointerventional devices is expected to restrain the growth of the market. Technological advancements such as robotics and integration of artificial intelligence (AI) in neurointerventional devices offer lucrative growth opportunity for the neurointerventional devices market.

The neurointerventional devices market is segmented on the basis of product, indication, end user, and region. By product type, the market is categorized into catheter, wires, stents, embolic coils, and others. The others include embolic protection device, and long sheath. By indication, the market is categorized into brain aneurysm, stroke, vascular malformations, and others. The others include vascular malformations, arteriovenous fistula, and arteriovenous malformation (AVM).

By end user, the market is categorized into hospitals and ambulatory surgical center. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). Major key players that operate in the global neurointerventional devices market are Stryker Corporation, Johnson & Johnson, Medtronic plc, Terumo Corporation, Lepu Medical Technology (Beijing) Co., Ltd, Merit Medical Systems Inc, Balt Group, Integer Holdings Corporation, Penumbra, Inc., and Cook Group Inc.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the neurointerventional devices market analysis from 2022 to 2032 to identify the prevailing neurointerventional devices market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the neurointerventional devices market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global neurointerventional devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

Stents
Embolic Coils
Catheter
Wires
Others

By Indication

Brain Aneurysm
Stroke
Others

By Application

Hospitals
Ambulatory Surgical Centers
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players:

Balt Group
Cook Group Inc
Integer Holdings Corporation
Johnson & Johnson
Lepu Medical Technology (Beijing) Co., Ltd
Medtronic plc
Merit Medical Systems Inc.
Penumbra, Inc
Stryker Corporation.
Terumo Corporation

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. Low bargaining power of suppliers
- 3.3.2. Low threat of new entrants
- 3.3.3. Low threat of substitutes
- 3.3.4. Low intensity of rivalry
- 3.3.5. Low bargaining power of buyers
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Surge in prevalence of neurological disorders
  - 3.4.1.2. Rise in awareness about neurological disorders
  - 3.4.1.3. Rise in demand for minimal invasive procedures

3.4.2. Restraints
- 3.4.2.1. High cost of neurointerventional devices

3.4.3. Opportunities
- 3.4.3.1. Technological advancement in neurointerventional devices

3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Stents
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Embolic Coils
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
4.4. Catheter
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
4.5. Wires
- 4.5.1. Key market trends, growth factors and opportunities
- 4.5.2. Market size and forecast, by region
- 4.5.3. Market share analysis by country
4.6. Others
- 4.6.1. Key market trends, growth factors and opportunities
- 4.6.2. Market size and forecast, by region
- 4.6.3. Market share analysis by country

CHAPTER 5: NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Brain Aneurysm
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Stroke
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Others
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country

CHAPTER 6: NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Hospitals
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Ambulatory Surgical Centers
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
6.4. Others
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country

CHAPTER 7: NEUROINTERVENTIONAL DEVICES MARKET, BY REGION

7.1. Overview
- 7.1.1. Market size and forecast By Region
7.2. North America
- 7.2.1. Key trends and opportunities
- 7.2.2. Market size and forecast, by Product
- 7.2.3. Market size and forecast, by Indication
- 7.2.4. Market size and forecast, by Application
- 7.2.5. Market size and forecast, by country
  - 7.2.5.1. U.S.
  - 7.2.5.1.1. Key market trends, growth factors and opportunities
  - 7.2.5.1.2. Market size and forecast, by Product
  - 7.2.5.1.3. Market size and forecast, by Indication
  - 7.2.5.1.4. Market size and forecast, by Application
  - 7.2.5.2. Canada
  - 7.2.5.2.1. Key market trends, growth factors and opportunities
  - 7.2.5.2.2. Market size and forecast, by Product
  - 7.2.5.2.3. Market size and forecast, by Indication
  - 7.2.5.2.4. Market size and forecast, by Application
  - 7.2.5.3. Mexico
  - 7.2.5.3.1. Key market trends, growth factors and opportunities
  - 7.2.5.3.2. Market size and forecast, by Product
  - 7.2.5.3.3. Market size and forecast, by Indication
  - 7.2.5.3.4. Market size and forecast, by Application
7.3. Europe
- 7.3.1. Key trends and opportunities
- 7.3.2. Market size and forecast, by Product
- 7.3.3. Market size and forecast, by Indication
- 7.3.4. Market size and forecast, by Application
- 7.3.5. Market size and forecast, by country
  - 7.3.5.1. Germany
  - 7.3.5.1.1. Key market trends, growth factors and opportunities
  - 7.3.5.1.2. Market size and forecast, by Product
  - 7.3.5.1.3. Market size and forecast, by Indication
  - 7.3.5.1.4. Market size and forecast, by Application
  - 7.3.5.2. France
  - 7.3.5.2.1. Key market trends, growth factors and opportunities
  - 7.3.5.2.2. Market size and forecast, by Product
  - 7.3.5.2.3. Market size and forecast, by Indication
  - 7.3.5.2.4. Market size and forecast, by Application
  - 7.3.5.3. UK
  - 7.3.5.3.1. Key market trends, growth factors and opportunities
  - 7.3.5.3.2. Market size and forecast, by Product
  - 7.3.5.3.3. Market size and forecast, by Indication
  - 7.3.5.3.4. Market size and forecast, by Application
  - 7.3.5.4. Italy
  - 7.3.5.4.1. Key market trends, growth factors and opportunities
  - 7.3.5.4.2. Market size and forecast, by Product
  - 7.3.5.4.3. Market size and forecast, by Indication
  - 7.3.5.4.4. Market size and forecast, by Application
  - 7.3.5.5. Spain
  - 7.3.5.5.1. Key market trends, growth factors and opportunities
  - 7.3.5.5.2. Market size and forecast, by Product
  - 7.3.5.5.3. Market size and forecast, by Indication
  - 7.3.5.5.4. Market size and forecast, by Application
  - 7.3.5.6. Rest of Europe
  - 7.3.5.6.1. Key market trends, growth factors and opportunities
  - 7.3.5.6.2. Market size and forecast, by Product
  - 7.3.5.6.3. Market size and forecast, by Indication
  - 7.3.5.6.4. Market size and forecast, by Application
7.4. Asia-Pacific
- 7.4.1. Key trends and opportunities
- 7.4.2. Market size and forecast, by Product
- 7.4.3. Market size and forecast, by Indication
- 7.4.4. Market size and forecast, by Application
- 7.4.5. Market size and forecast, by country
  - 7.4.5.1. Japan
  - 7.4.5.1.1. Key market trends, growth factors and opportunities
  - 7.4.5.1.2. Market size and forecast, by Product
  - 7.4.5.1.3. Market size and forecast, by Indication
  - 7.4.5.1.4. Market size and forecast, by Application
  - 7.4.5.2. China
  - 7.4.5.2.1. Key market trends, growth factors and opportunities
  - 7.4.5.2.2. Market size and forecast, by Product
  - 7.4.5.2.3. Market size and forecast, by Indication
  - 7.4.5.2.4. Market size and forecast, by Application
  - 7.4.5.3. Australia
  - 7.4.5.3.1. Key market trends, growth factors and opportunities
  - 7.4.5.3.2. Market size and forecast, by Product
  - 7.4.5.3.3. Market size and forecast, by Indication
  - 7.4.5.3.4. Market size and forecast, by Application
  - 7.4.5.4. India
  - 7.4.5.4.1. Key market trends, growth factors and opportunities
  - 7.4.5.4.2. Market size and forecast, by Product
  - 7.4.5.4.3. Market size and forecast, by Indication
  - 7.4.5.4.4. Market size and forecast, by Application
  - 7.4.5.5. South Korea
  - 7.4.5.5.1. Key market trends, growth factors and opportunities
  - 7.4.5.5.2. Market size and forecast, by Product
  - 7.4.5.5.3. Market size and forecast, by Indication
  - 7.4.5.5.4. Market size and forecast, by Application
  - 7.4.5.6. Rest of Asia-Pacific
  - 7.4.5.6.1. Key market trends, growth factors and opportunities
  - 7.4.5.6.2. Market size and forecast, by Product
  - 7.4.5.6.3. Market size and forecast, by Indication
  - 7.4.5.6.4. Market size and forecast, by Application
7.5. LAMEA
- 7.5.1. Key trends and opportunities
- 7.5.2. Market size and forecast, by Product
- 7.5.3. Market size and forecast, by Indication
- 7.5.4. Market size and forecast, by Application
- 7.5.5. Market size and forecast, by country
  - 7.5.5.1. Brazil
  - 7.5.5.1.1. Key market trends, growth factors and opportunities
  - 7.5.5.1.2. Market size and forecast, by Product
  - 7.5.5.1.3. Market size and forecast, by Indication
  - 7.5.5.1.4. Market size and forecast, by Application
  - 7.5.5.2. Saudi Arabia
  - 7.5.5.2.1. Key market trends, growth factors and opportunities
  - 7.5.5.2.2. Market size and forecast, by Product
  - 7.5.5.2.3. Market size and forecast, by Indication
  - 7.5.5.2.4. Market size and forecast, by Application
  - 7.5.5.3. South Africa
  - 7.5.5.3.1. Key market trends, growth factors and opportunities
  - 7.5.5.3.2. Market size and forecast, by Product
  - 7.5.5.3.3. Market size and forecast, by Indication
  - 7.5.5.3.4. Market size and forecast, by Application
  - 7.5.5.4. Rest of LAMEA
  - 7.5.5.4.1. Key market trends, growth factors and opportunities
  - 7.5.5.4.2. Market size and forecast, by Product
  - 7.5.5.4.3. Market size and forecast, by Indication
  - 7.5.5.4.4. Market size and forecast, by Application

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

9.1. Stryker Corporation.
- 9.1.1. Company overview
- 9.1.2. Key Executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Business performance
- 9.1.7. Key strategic moves and developments
9.2. Johnson & Johnson
- 9.2.1. Company overview
- 9.2.2. Key Executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business performance
- 9.2.7. Key strategic moves and developments
9.3. Medtronic plc
- 9.3.1. Company overview
- 9.3.2. Key Executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.3.6. Business performance
9.4. Terumo Corporation
- 9.4.1. Company overview
- 9.4.2. Key Executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.4.6. Business performance
- 9.4.7. Key strategic moves and developments
9.5. Integer Holdings Corporation
- 9.5.1. Company overview
- 9.5.2. Key Executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
- 9.5.6. Business performance
- 9.5.7. Key strategic moves and developments
9.6. Lepu Medical Technology (Beijing) Co., Ltd
- 9.6.1. Company overview
- 9.6.2. Key Executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.6.6. Business performance
9.7. Balt Group
- 9.7.1. Company overview
- 9.7.2. Key Executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
9.8. Merit Medical Systems Inc.
- 9.8.1. Company overview
- 9.8.2. Key Executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
- 9.8.6. Business performance
9.9. Cook Group Inc
- 9.9.1. Company overview
- 9.9.2. Key Executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
9.10. Penumbra, Inc
- 9.10.1. Company overview
- 9.10.2. Key Executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio
- 9.10.6. Business performance

神経インターベンション装置市場：製品別、適応症別、用途別：世界の機会分析と産業予測、2023-2032年

Neurointerventional Devices Market By Product, By Indication, By Application : Global Opportunity Analysis and Industry Forecast, 2023-2032

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章神経インターベンション装置市場：製品別

第5章神経インターベンション装置市場：適応疾患別

第6章神経インターベンション装置市場：用途別

第7章神経インターベンション装置市場：地域別

第8章競争情勢

第9章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Benefits For Stakeholders

Key Market Segments

By Product

By Indication

By Application

By Region

Key Market Players:

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT

CHAPTER 5: NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION

CHAPTER 6: NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION

CHAPTER 7: NEUROINTERVENTIONAL DEVICES MARKET, BY REGION

CHAPTER 8: COMPETITIVE LANDSCAPE

CHAPTER 9: COMPANY PROFILES

神経インターベンション装置市場：製品別、適応症別、用途別：世界の機会分析と産業予測、2023-2032年

Neurointerventional Devices Market By Product, By Indication, By Application : Global Opportunity Analysis and Industry Forecast, 2023-2032

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

第4章 神経インターベンション装置市場：製品別

第5章 神経インターベンション装置市場：適応疾患別

第6章 神経インターベンション装置市場：用途別

第7章 神経インターベンション装置市場：地域別

第8章 競争情勢

第9章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Benefits For Stakeholders

Key Market Segments

By Product

By Indication

By Application

By Region

Key Market Players:

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT

CHAPTER 5: NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION

CHAPTER 6: NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION

CHAPTER 7: NEUROINTERVENTIONAL DEVICES MARKET, BY REGION

CHAPTER 8: COMPETITIVE LANDSCAPE

CHAPTER 9: COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章神経インターベンション装置市場：製品別

第5章神経インターベンション装置市場：適応疾患別

第6章神経インターベンション装置市場：用途別

第7章神経インターベンション装置市場：地域別

第8章競争情勢

第9章企業プロファイル